Early Confirmed Speakers

 

 

John Alter, Vice President Pricing and Market Access, Pfizer

John Alter at Pharma Pricing & Market Access Congress 2019

Diego Ardigo, R&D Rare Diseases Unit Head, Chiesi Farmaceutici SpA

Diego Ardigo at Pharma Pricing & Market Access Congress 2019

Francis Arickx, Head of the Directorate Reimbursement of Medicines and Pharmaceutical Policy,, National Institute for Health and Disability Insurance RIZIV-INAMI

Francis Arickx at Pharma Pricing & Market Access Congress 2019

Nadeem Ashraf, Digital Medical Lead, Eli Lilly And Company

Nadeem Ashraf at Pharma Pricing & Market Access Congress 2019

Katja Berg, Vice President of Operations and Payers Intelligence, Sanofi

Katja Berg at Pharma Pricing & Market Access Congress 2019

Axel Boehnke, Director Market Access (global responsibility), MorphoSys AG

Axel Boehnke at Pharma Pricing & Market Access Congress 2019

Luc Boileau, Président-directeur general, Inesss

Luc Boileau at Pharma Pricing & Market Access Congress 2019

David Boothe, Regional Commercial Head, Spark Therapeutics

David Boothe at Pharma Pricing & Market Access Congress 2019

Hassan Bruneo, Associate Director, Alnylam Switzerland Gmbh

Hassan Bruneo at Pharma Pricing & Market Access Congress 2019

Anna Bucsics, Project Advisor, Mechanism of Coordinated Access to orphan medicinal products (MoCA)

Anna Bucsics at Pharma Pricing & Market Access Congress 2019

Hector Castro, Senior Technical Director- Pharmaceutical Economics & Financing, Management Science For Health

Hector Castro at Pharma Pricing & Market Access Congress 2019

Deven Chauhan, Senior Director, Value Evidence Leader, GlaxoSmithKline

Deven Chauhan at Pharma Pricing & Market Access Congress 2019

José Luis Sánchez Chorro, Head of Market Access, Shire Pharmaceuticals

José Luis Sánchez Chorro at Pharma Pricing & Market Access Congress 2019

Laura Cockram, Head of Policy and Campaigns, Parkinson's UK

Laura Cockram at Pharma Pricing & Market Access Congress 2019

Mike Crosher, Value & Access Director, Chugai Pharma UK

Mike Crosher at Pharma Pricing & Market Access Congress 2019

Omar Dabbous, Vice President Health Economics and Outcomes Research, AveXis Inc

Omar Dabbous at Pharma Pricing & Market Access Congress 2019

Natalya Danchenko, Global Market Access and Pricing Director, Ipsen

Natalya Danchenko at Pharma Pricing & Market Access Congress 2019

Charles De Cidrac, AXA

Charles De Cidrac at Pharma Pricing & Market Access Congress 2019

Will Dunlop, Head of Market Access, Mundipharma International Limited

Will Dunlop at Pharma Pricing & Market Access Congress 2019

Jenny Ebert, Account Director, Genzyme Sanofi Corp

Jenny Ebert at Pharma Pricing & Market Access Congress 2019

David Elvira Martinez, Director of the Catalan Health Service, CatSalut, Catalunya Health Service

David Elvira Martinez at Pharma Pricing & Market Access Congress 2019

Diar Fattah, Associate Director of Medicines Optimisation, N.H.S._Dartford Gravesham and Swanley C.C.G.

Diar Fattah at Pharma Pricing & Market Access Congress 2019

Matteo Ferrario, Value Strategy Manager, Roche

Matteo Ferrario at Pharma Pricing & Market Access Congress 2019

Steven Flostrand, Senior Director of Pricing and Market Access, Celgene

Steven Flostrand at Pharma Pricing & Market Access Congress 2019

Adrian Griffin, VP, HTA and Reimbursement Policy, Johnson & Johnson

Adrian Griffin at Pharma Pricing & Market Access Congress 2019

Mohamed Hamada, Country Portfolio Lead, Women’s Health – Egypt & Sudan, Pfizer

Mohamed Hamada at Pharma Pricing & Market Access Congress 2019

Chris Hill, Head of Strategic Pricing UK & Ireland, Sanofi

Chris Hill at Pharma Pricing & Market Access Congress 2019

Alan Hochberg, Process Development Leader and DSC Office, F. Hoffmann-La Roche Ltd

Alan Hochberg at Pharma Pricing & Market Access Congress 2019

Karen Hockey, Director, Global Market Access & Government Affairs, Norgine Ltd

Karen Hockey at Pharma Pricing & Market Access Congress 2019

Dai Hozumi, Senior Director, Management Science For Health

Dai Hozumi at Pharma Pricing & Market Access Congress 2019

Jenny Hughes, Head, Market Access Capabilities, GSK

Jenny Hughes at Pharma Pricing & Market Access Congress 2019

Wills Hughes-Wilson, Head of Patient Access & Commercial Planning, Mereo BioPharma

Wills Hughes-Wilson at Pharma Pricing & Market Access Congress 2019

Dawn Ireland, President, CDH International

Dawn Ireland at Pharma Pricing & Market Access Congress 2019

Daniel Jackson, Global Head of Market Access, Solutions and Strategy, UCB

Daniel Jackson at Pharma Pricing & Market Access Congress 2019

Navin Joshi, Head of Pricing & Access Capabilities EMAP, GlaxoSmithKline

Navin Joshi at Pharma Pricing & Market Access Congress 2019

Etienne Jousseaume, Head Market Access Cell & Gene Therapies Europe, Novartis Oncology

Etienne Jousseaume at Pharma Pricing & Market Access Congress 2019

Marcela Junqueira, Head of Value Demonstration and Access, Shire Farmacêutica Brasil Ltda

Marcela Junqueira at Pharma Pricing & Market Access Congress 2019

Sachin Kamal-Bahl, Vice President & Head, Global Health & Value Innovation Center, Pfizer

Sachin Kamal-Bahl at Pharma Pricing & Market Access Congress 2019

Jolanda Koenders, Head of Pricing and Market Access Pharma, Novartis

Jolanda Koenders at Pharma Pricing & Market Access Congress 2019

Sebastien Le Roux, VP, Global Market Access & Healthcare Solutions, Glaxo Smith Kline Inc

Sebastien Le Roux at Pharma Pricing & Market Access Congress 2019

Michael Lees, Head of Value, Evidence & Portfolio Strategy, Takeda

Michael Lees at Pharma Pricing & Market Access Congress 2019

Friedhelm Leverkus, Director Health Technology Assessment and Outcomes Research, Pfizer

Friedhelm Leverkus at Pharma Pricing & Market Access Congress 2019

Gordon Lundie, Director of Market Access, Gilead Sciences

Gordon Lundie at Pharma Pricing & Market Access Congress 2019

Steinar Madsen, Medical Director, Norwegian Medicines Agency, Norway

Steinar Madsen at Pharma Pricing & Market Access Congress 2019

Joerg Mahlich, Head HEOR, Janssen Pharmaceutical K.K.

Joerg Mahlich at Pharma Pricing & Market Access Congress 2019

Farzana Malik, Vice President Market Access, Vicarius Pharma

Farzana Malik at Pharma Pricing & Market Access Congress 2019

Andrea Mantovani, Director of Country Market Access, Amgen Inc

Andrea Mantovani at Pharma Pricing & Market Access Congress 2019

Anne Marciniak, Affiliate, BRUNEL UNIVERSITY

Anne Marciniak at Pharma Pricing & Market Access Congress 2019

Cristina Martin-Rinconada, Associate Director Strategic Pricing, Biogen Biosimilars Europe

Cristina Martin-Rinconada at Pharma Pricing & Market Access Congress 2019

Jeff Myers, CEO, Medicaid Health Plans of America

Jeff Myers at Pharma Pricing & Market Access Congress 2019

Sue Naeyaert, Global Head Government Affairs and Policy Biosimilars, Fresenius Kabi

Sue Naeyaert at Pharma Pricing & Market Access Congress 2019

Alexander Natz, Secretary General, EUCOPE

Alexander Natz at Pharma Pricing & Market Access Congress 2019

Enkeleida Nikai, Director of RWE - Medical Affairs, Eli Lilly

Enkeleida Nikai at Pharma Pricing & Market Access Congress 2019

Melvin "Skip" Olson, Global Head RWD Strategy and Innovation, Novartis Pharma

Melvin "Skip" Olson at Pharma Pricing & Market Access Congress 2019

Nneka Onwudiwe, PRO/PE Scientific Reviewer, Food and Drug Administration

Nneka Onwudiwe at Pharma Pricing & Market Access Congress 2019

Robert Orzechowski, Chief Operating Officer, Lancaster Cancer Centre

Robert Orzechowski at Pharma Pricing & Market Access Congress 2019

Elena Panitti, Global RWE Capability Building Lead, Novartis

Elena Panitti at Pharma Pricing & Market Access Congress 2019

Detlev Parow, Head of Department of Medicines, Therapeutic Appliances and Remedies, D.A.K.

Detlev Parow at Pharma Pricing & Market Access Congress 2019

Marco Penske, Head of Market Access and Health Care Affairs, Boehringer Ingelheim Biopharmaceuticals Gmbh

Marco Penske at Pharma Pricing & Market Access Congress 2019

Ana Plata, Global Head Access Strategy for New Medicines, UCB

Ana Plata at Pharma Pricing & Market Access Congress 2019

Tanya Potashnik, Director Policy & Economic Analysis, Patented Medicine Prices Review Board, Goverment Of Canada

Tanya Potashnik at Pharma Pricing & Market Access Congress 2019

Diann Potestio, Senior Director, National Accounts, Multiple Sclerosis & Immunology, Genzyme

Diann Potestio at Pharma Pricing & Market Access Congress 2019

David Pritchard, Vice President and Area Head Africa and Developing Countries, GSK

David Pritchard at Pharma Pricing & Market Access Congress 2019

David Pritchard, Vice President and Area Head Africa and Developing Countries, GSK

David Pritchard at Pharma Pricing & Market Access Congress 2019

Marco Rauland, Global Head Pricing & Payer Excellence, Merck Group

Marco Rauland at Pharma Pricing & Market Access Congress 2019

Andrew Richards, Head of Global Market Access & Pricing, Ferring

Andrew Richards at Pharma Pricing & Market Access Congress 2019

Igor Rudychev, Sr. Director, Business Insights, Immuno-Oncology, AstraZeneca

Igor Rudychev at Pharma Pricing & Market Access Congress 2019

Gundula Schneidewind, Managing Director, Takeda Belgium

Gundula Schneidewind at Pharma Pricing & Market Access Congress 2019

Michael Schroter, Head of Personalised Reimbursment Models, Global Pricing and Market Access, Roche

Michael Schroter at Pharma Pricing & Market Access Congress 2019

Rob Scott, Chief Medical Officer, VP, Head of Development, AbbVie

Rob Scott at Pharma Pricing & Market Access Congress 2019

Simon Shohet, Senior Director, Global Market Access and Pricing, Ipsen

Simon Shohet at Pharma Pricing & Market Access Congress 2019

Gerard Slevin, National hospitals manager, Clonmel Healthcare Ltd

Gerard Slevin at Pharma Pricing & Market Access Congress 2019

Erik Smets, Vice President and Head of Patient Experience and Value, UCB Biopharma

Erik Smets at Pharma Pricing & Market Access Congress 2019

Anastasiya Stepanova, State Authorities Manager, JSC Nizhpharm

Anastasiya Stepanova at Pharma Pricing & Market Access Congress 2019

Richard Stephens, Chair of Consumer Liaison Group, National Cancer Research Institute (NCRI)

Richard Stephens at Pharma Pricing & Market Access Congress 2019

Daria Tolkacheva, Head of Health Economics, JSC BIOCAD

Daria Tolkacheva at Pharma Pricing & Market Access Congress 2019

Jörg Tomeczkowski, Head of Market Access, Janssen Cilag Germany

Jörg Tomeczkowski at Pharma Pricing & Market Access Congress 2019

Keiko Tone, VP Market Access, Shionogi Limited

Keiko Tone at Pharma Pricing & Market Access Congress 2019

Isabel Torres, Vice President Market Access, Public Affairs and Patient Advocacy for Europe and Canada, Takeda

Isabel Torres at Pharma Pricing & Market Access Congress 2019

Dimitrios Tsourougiannis, Associate Director, EMEA Health Economics & Outcomes Research, Astellas Pharma Europe Ltd

Dimitrios Tsourougiannis at Pharma Pricing & Market Access Congress 2019

Florian Turk, Head of Global Payor Marketing, Sales and Relations, Sandoz

Florian Turk at Pharma Pricing & Market Access Congress 2019

Sheela Upadhyaya, Associate Director Highly Specialised Technologies, National Institute for Health and Care Excellence

Sheela Upadhyaya at Pharma Pricing & Market Access Congress 2019

Sheela Upadhyaya, Associate Director Highly Specialised Technologies, National Institute for Health and Care Excellence

Sheela Upadhyaya at Pharma Pricing & Market Access Congress 2019

Maarten Van Baelen, Market Access Director, Medicines for Europe

Maarten Van Baelen at Pharma Pricing & Market Access Congress 2019

Bart Vermeulen, Deputy Director Healthcare at Office of the Minister of Social Affairs and Public Health, Belgian Federal Government

Bart Vermeulen at Pharma Pricing & Market Access Congress 2019

Reg Waldeck, Market Access Strategy Leader, Bayer Corp

Reg Waldeck at Pharma Pricing & Market Access Congress 2019

Darren Walsh, Senior Director - Market Access & Govt. Affairs – EU, Orchard Therapeutics

Darren Walsh at Pharma Pricing & Market Access Congress 2019

David Watson, Director Pricing and Reimbursement, Association of the British Pharmaceutical Industry

David Watson at Pharma Pricing & Market Access Congress 2019

Clive Whitcher, VP Global Pricing and Patient Access, Sobi (Swedish Orphan Biovitrum)

Clive Whitcher at Pharma Pricing & Market Access Congress 2019

Fabrizio Zucca, Director Patient Access DACH, Sobi

Fabrizio Zucca at Pharma Pricing & Market Access Congress 2019

 

DOWNLOAD PROSPECTUS